Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants

Cristina Razquin, Sara Ortega-Cubero, Estefania Rojo-Bustamante, Monica Diez-Fairen, Elena Lorenzo, Elena Alonso, Mario Ezquerra, Owen A Ross, Maria Carcel, Oswaldo Lorenzo-Betancor, Alexandra I. Soto, Jeremy D. Burgess, Nilufer Taner, Dennis W Dickson, Maria A. Pastor, Eduard Tolosa, Pau Pastor

Research output: Contribution to journalArticle

Abstract

The main genetic risk factors for progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are located at chromosome 17q21.31. The identification of risk H1 subhaplotypes suggests that disease-specific variants can be identified by resequencing the 17q21.31 region (1.4 Mb) in carriers of risk H1 subhaplotypes. We hypothesized that PSP/CBD H1 subhaplotype carriers could have undergone a mutational event absent among unaffected carriers leading to the disease risk. We performed this strategy in definite PSP subjects, definite CBD subjects, and healthy controls and tried to replicate the findings in a larger PSP/CBD case-control series. In the resequencing process, 40 candidate variants were identified, but an association between PSP and rs76970862 was replicated only using an unadjusted model. Gene expression association analysis of this variant suggested no potential functional effect. Although our results failed to identify disease-associated variants, it is still possible that the risk of PSP/CBD at chromosome 17 is driven by rare variants, even in PSP/CBD H1 cases or variants located outside the capture regions.

Original languageEnglish (US)
JournalNeurobiology of Aging
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Tauopathies
Progressive Supranuclear Palsy
Chromosomes
Chromosomes, Human, Pair 17
Healthy Volunteers
Gene Expression

Keywords

  • Genetics
  • MAPT
  • Progressive supranuclear palsy

ASJC Scopus subject areas

  • Neuroscience(all)
  • Aging
  • Clinical Neurology
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Razquin, C., Ortega-Cubero, S., Rojo-Bustamante, E., Diez-Fairen, M., Lorenzo, E., Alonso, E., ... Pastor, P. (Accepted/In press). Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2017.12.026

Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants. / Razquin, Cristina; Ortega-Cubero, Sara; Rojo-Bustamante, Estefania; Diez-Fairen, Monica; Lorenzo, Elena; Alonso, Elena; Ezquerra, Mario; Ross, Owen A; Carcel, Maria; Lorenzo-Betancor, Oswaldo; Soto, Alexandra I.; Burgess, Jeremy D.; Taner, Nilufer; Dickson, Dennis W; Pastor, Maria A.; Tolosa, Eduard; Pastor, Pau.

In: Neurobiology of Aging, 01.01.2018.

Research output: Contribution to journalArticle

Razquin, C, Ortega-Cubero, S, Rojo-Bustamante, E, Diez-Fairen, M, Lorenzo, E, Alonso, E, Ezquerra, M, Ross, OA, Carcel, M, Lorenzo-Betancor, O, Soto, AI, Burgess, JD, Taner, N, Dickson, DW, Pastor, MA, Tolosa, E & Pastor, P 2018, 'Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants', Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2017.12.026
Razquin, Cristina ; Ortega-Cubero, Sara ; Rojo-Bustamante, Estefania ; Diez-Fairen, Monica ; Lorenzo, Elena ; Alonso, Elena ; Ezquerra, Mario ; Ross, Owen A ; Carcel, Maria ; Lorenzo-Betancor, Oswaldo ; Soto, Alexandra I. ; Burgess, Jeremy D. ; Taner, Nilufer ; Dickson, Dennis W ; Pastor, Maria A. ; Tolosa, Eduard ; Pastor, Pau. / Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants. In: Neurobiology of Aging. 2018.
@article{05459be2d1be4fc39d63557188401a36,
title = "Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants",
abstract = "The main genetic risk factors for progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are located at chromosome 17q21.31. The identification of risk H1 subhaplotypes suggests that disease-specific variants can be identified by resequencing the 17q21.31 region (1.4 Mb) in carriers of risk H1 subhaplotypes. We hypothesized that PSP/CBD H1 subhaplotype carriers could have undergone a mutational event absent among unaffected carriers leading to the disease risk. We performed this strategy in definite PSP subjects, definite CBD subjects, and healthy controls and tried to replicate the findings in a larger PSP/CBD case-control series. In the resequencing process, 40 candidate variants were identified, but an association between PSP and rs76970862 was replicated only using an unadjusted model. Gene expression association analysis of this variant suggested no potential functional effect. Although our results failed to identify disease-associated variants, it is still possible that the risk of PSP/CBD at chromosome 17 is driven by rare variants, even in PSP/CBD H1 cases or variants located outside the capture regions.",
keywords = "Genetics, MAPT, Progressive supranuclear palsy",
author = "Cristina Razquin and Sara Ortega-Cubero and Estefania Rojo-Bustamante and Monica Diez-Fairen and Elena Lorenzo and Elena Alonso and Mario Ezquerra and Ross, {Owen A} and Maria Carcel and Oswaldo Lorenzo-Betancor and Soto, {Alexandra I.} and Burgess, {Jeremy D.} and Nilufer Taner and Dickson, {Dennis W} and Pastor, {Maria A.} and Eduard Tolosa and Pau Pastor",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.neurobiolaging.2017.12.026",
language = "English (US)",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants

AU - Razquin, Cristina

AU - Ortega-Cubero, Sara

AU - Rojo-Bustamante, Estefania

AU - Diez-Fairen, Monica

AU - Lorenzo, Elena

AU - Alonso, Elena

AU - Ezquerra, Mario

AU - Ross, Owen A

AU - Carcel, Maria

AU - Lorenzo-Betancor, Oswaldo

AU - Soto, Alexandra I.

AU - Burgess, Jeremy D.

AU - Taner, Nilufer

AU - Dickson, Dennis W

AU - Pastor, Maria A.

AU - Tolosa, Eduard

AU - Pastor, Pau

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The main genetic risk factors for progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are located at chromosome 17q21.31. The identification of risk H1 subhaplotypes suggests that disease-specific variants can be identified by resequencing the 17q21.31 region (1.4 Mb) in carriers of risk H1 subhaplotypes. We hypothesized that PSP/CBD H1 subhaplotype carriers could have undergone a mutational event absent among unaffected carriers leading to the disease risk. We performed this strategy in definite PSP subjects, definite CBD subjects, and healthy controls and tried to replicate the findings in a larger PSP/CBD case-control series. In the resequencing process, 40 candidate variants were identified, but an association between PSP and rs76970862 was replicated only using an unadjusted model. Gene expression association analysis of this variant suggested no potential functional effect. Although our results failed to identify disease-associated variants, it is still possible that the risk of PSP/CBD at chromosome 17 is driven by rare variants, even in PSP/CBD H1 cases or variants located outside the capture regions.

AB - The main genetic risk factors for progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are located at chromosome 17q21.31. The identification of risk H1 subhaplotypes suggests that disease-specific variants can be identified by resequencing the 17q21.31 region (1.4 Mb) in carriers of risk H1 subhaplotypes. We hypothesized that PSP/CBD H1 subhaplotype carriers could have undergone a mutational event absent among unaffected carriers leading to the disease risk. We performed this strategy in definite PSP subjects, definite CBD subjects, and healthy controls and tried to replicate the findings in a larger PSP/CBD case-control series. In the resequencing process, 40 candidate variants were identified, but an association between PSP and rs76970862 was replicated only using an unadjusted model. Gene expression association analysis of this variant suggested no potential functional effect. Although our results failed to identify disease-associated variants, it is still possible that the risk of PSP/CBD at chromosome 17 is driven by rare variants, even in PSP/CBD H1 cases or variants located outside the capture regions.

KW - Genetics

KW - MAPT

KW - Progressive supranuclear palsy

UR - http://www.scopus.com/inward/record.url?scp=85041629766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041629766&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2017.12.026

DO - 10.1016/j.neurobiolaging.2017.12.026

M3 - Article

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

ER -